The recent endorsement of Neuraxpharm's ublituximab (BRIUMVI®) by the National Institute for Health and Care Excellence (NICE) marks a significant step forward in the treatment of relapsing-remitting multiple sclerosis (RRMS). This approval is a notable accomplishment for the European specialty
A recent study spearheaded by University of South Florida (USF) Health researchers, in collaboration with TGH Cancer Institute, has unveiled a potential link between ultra-processed foods and an increased risk of colorectal cancer. Researchers highlighted how these foods may contribute to chronic
The integration of artificial intelligence (AI) in healthcare is rapidly advancing, promising significant improvements in patient care and operational efficiency. Nonetheless, as this technological leap transforms medical practices, it also raises critical ethical considerations, particularly
Alzheimer’s disease (AD) is a progressive neurodegenerative condition that significantly impacts memory, cognition, and behavior. Early detection is crucial for effective intervention, especially with the development of new anti-amyloid therapies. However, traditional diagnostic tools face
The PROSPECT-Lung trial has officially commenced, heralding a significant advance in the quest to enhance treatment strategies for patients with resectable non-small cell lung cancer (NSCLC). This trial marks the inaugural endeavor of the newly established National Cancer Institute (NCI) Clinical
Respiratory Syncytial Virus (RSV) is a common virus that infects nearly all children by the age of two, but while most cases are mild, some children experience severe respiratory illness that requires hospitalization. The mechanisms behind this severity, especially the role and dysfunction of
The emergence of highly pathogenic avian influenza (HPAI) H5N1 in 1996 marked a significant event in the history of infectious diseases. Over the years, this virus has spread across continents, infecting various species and creating diverse clades. The potential for H5N1 to adapt to humans through
Drug addiction has been a persistent issue throughout human history, documented from ancient times. Traditionally viewed as a moral failing rather than a treatable disease, the perception of addiction began to shift in the 20th century with scientific discoveries highlighting its basis in brain
In a remarkable breakthrough in breast cancer treatment, a novel cell-based immunotherapy developed by Dr. Gary Koski from Kent State University and Dr. Brian J. Czerniecki from the Moffitt Cancer Center has been recently accepted for publication in JAMA Oncology. This innovative approach harnesses
Earlier this week, the U.S. Food and Drug Administration (FDA) unveiled its much-anticipated final guidance on predetermined change control plans (PCCPs) for devices incorporating artificial intelligence and machine learning (AI/ML) software. This guidance signifies a significant milestone in the
